Abstract
Biosurfactants have gained more attention in the past decade as possible medical resources. They are useful therapeutic agents against many infections because of their antibacterial, antifungal, and antiviral properties. Additionally, the anti-adherent activities of these compounds counter to a number of pathogens suggest that they could be useful as an anti-adherent coating for medical inserts, helping to prevent infections in hospitals without the use of chemicals. This study aims to investigate the antiadhesive activities of biosurfactants extracted from Lactobacillus brevis and Bacillus sp. against seven clinical pathogens. Biosurfactants at different concentrations were applied to polystyrene surfaces, and then the attachment of pathogenic strains was evaluated. The adhesion of microbes to n-hexadecane was also studied. As a result, the bacterial strains with 50 mg/ml of Lactobacillus brevis biosurfactant displayed a 69-73% reduction in adhesion. In contrast to the first biosurfactant, a biosurfactant extracted from Bacillus sp. significantly reduced bacterial attachment at all concentrations studied, although to a lesser extent. As the concentration was increased in surface conditioning tests, the anti-adhesive activity increased, showing the significance of considering this. In summary, both biosurfactants demonstrated excellent potential as anti-adhesive compounds that can prevent microbial contamination. Our findings provided evidence that biosurfactants could be used in medical applications.